hephaistos.bio is addressing this challenge by combining computational biology, chemistry, machine learning, and structural biology to design custom protein catalysts tailored to specific industrial processes.
hephaistos.bio has raised €161k across 1 funding round from 1 investor, most recently a round in Jun 2026. Based in Zurich, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-06-01 | Other |
| €161k |
| Venture Kick |
| View deal → |
